Results 161 to 170 of about 12,991 (277)

Beyond Preeclampsia: Focal and Segmental Glomerulosclerosis Presenting as Nephrotic‐Range Proteinuria During Pregnancy, A Clinical Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
Nephrotic‐range proteinuria during pregnancy is not always preeclampsia. This case illustrates a steroid‐responsive tip‐variant podocytopathy with normal angiogenic biomarkers (sFlt‐1/PlGF), supporting a non‐placental origin. Renal biopsy confirmed the diagnosis, while concurrent CMV infection may have acted as a potential immunologic trigger ...
Sierra Acuña Ximena Rosario   +1 more
wiley   +1 more source

Whole-exome sequencing in pediatric patients with glomerulonephritis. [PDF]

open access: yesFront Genet
Peric M   +9 more
europepmc   +1 more source

Gestational Diabetes and Long‐Term Risk of Maternal Kidney Disease: Systematic Review and Meta‐Analysis of Population Base Cohort Studies

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
GDM with and without DM was significantly associated with an increased risk of maternal CKD. GDM with DM had a synergistic effect on maternal CKD risk. Women who experience GDM during their pregnancy, especially those who later develop diabetes, should be well informed about their long‐term risk of kidney disease.
Mansour Bahardoust   +7 more
wiley   +1 more source

No lupus nephritis in the absence of antiC1q autoantibodies? [PDF]

open access: yes, 2017
Frémeaux‐Bacchi, Véronique   +2 more
core  

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair [PDF]

open access: yes
Balbín Felechosa, Milagros   +6 more
core   +1 more source

The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The integration of biosimilars into pediatric healthcare represents a significant evolution in treatment accessibility and cost‐effectiveness. Biosimilars—biological products highly similar to already approved biologics, have emerged as promising alternatives for managing chronic and rare pediatric conditions, including ...
Zubaier Ahmed   +6 more
wiley   +1 more source

miRNAs in Glomerular Diseases: From Pathogenic Insight to Therapeutic Potential: A Narrative Review. [PDF]

open access: yesCells
Apetrii M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy